# Piero Picci

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/piero-picci/

## Facts

| Field | Value |
| --- | --- |
| Citations | 42,654 |
| Field | Sarcoma Diagnosis and Treatment |
| h-index | 106 |
| i10-index | 487 |
| Last Known Institution | Istituto Ortopedico Rizzoli |
| OpenAlex ID | https://openalex.org/A5083948167 |
| ORCID iD | https://orcid.org/0000-0002-8519-4101 |
| Works | 992 |

## Researcher papers

Showing 12 of 14.

- [Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/soft-tissue-and-visceral-sarcomas-esmo-euracan-clinical-practice-guidelines-for/)
- [Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastrointestinal-stromal-tumours-esmo-euracan-clinical-practice-guidelines-for/)
- [Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/bone-sarcomas-esmo-paedcan-euracan-clinical-practice-guidelines-for-diagnosis/)
- [Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial](https://scholariq.org/papers/histotype-tailored-neoadjuvant-chemotherapy-versus-standard-chemotherapy-in/)
- [Platelet-derived growth factors enhance proliferation of human stromal stem cells](https://scholariq.org/papers/platelet-derived-growth-factors-enhance-proliferation-of-human-stromal-stem/)
- [Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma.](https://scholariq.org/papers/relationship-of-chemotherapy-induced-necrosis-and-surgical-margins-to-local/)
- [Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression](https://scholariq.org/papers/canine-tumor-cross-species-genomics-uncovers-targets-linked-to-osteosarcoma/)
- [Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups](https://scholariq.org/papers/neoadjuvant-chemotherapy-in-high-risk-soft-tissue-sarcomas-final-results-of-a/)
- [Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities.](https://scholariq.org/papers/chemotherapy-induced-tumor-necrosis-as-a-prognostic-factor-in-localized-ewing-s/)
- [Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma](https://scholariq.org/papers/frequency-of-pathogenic-germline-variants-in-cancer-susceptibility-genes-in/)
- [Corrections to “Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”](https://scholariq.org/papers/corrections-to-soft-tissue-and-visceral-sarcomas-esmo-euracan-clinical-practice/)
- [Genome-wide association study identifies two susceptibility loci for osteosarcoma](https://scholariq.org/papers/genome-wide-association-study-identifies-two-susceptibility-loci-for/)

## Researcher topics

- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Bone Tumor Diagnosis and Treatments](https://scholariq.org/topics/bone-tumor-diagnosis-and-treatments/)
- [Vascular Tumors and Angiosarcomas](https://scholariq.org/topics/vascular-tumors-and-angiosarcomas-2/)
- [Cardiac tumors and thrombi](https://scholariq.org/topics/cardiac-tumors-and-thrombi/)
- [Management of metastatic bone disease](https://scholariq.org/topics/management-of-metastatic-bone-disease/)

## Researcher university

- [Istituto Ortopedico Rizzoli](https://scholariq.org/institutions/istituto-ortopedico-rizzoli/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.